GlassScriptPhysician profile
Jigar D Patel
NPI 1225000532
$9,995.98
in general payments reported to CMS, 2019-2025
21 companies · $565 in 2025
The $565 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,762 · 2020: $520 · 2021: $883 · 2022: $1,256 · 2023: $1,065 · 2024: $945 · 2025: $565.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,575.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,574.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,066.26 | 2021-2025 | Micra, Azure Xt Dr Mri Surescan, Cobalt Dr Mri Surescan |
| Janssen Pharmaceuticals, INC | $2,796.46 | 2019-2022 | |
| Abbott Laboratories | $1,806.44 | 2019-2024 | Aveir, Mitraclip, Gallant |
| Biotronik INC. | $387.67 | 2019-2024 | Amvia Edge |
| Boston Scientific Corporation | $348.15 | 2019-2025 | General - Therapies, Accolade Sr, Rhythmia Mapping System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $347.04 | 2019-2024 | Lifevest |
| Biosense Webster, INC. | $273.48 | 2019-2022 | |
| Medtronic Vascular, INC. | $184.45 | 2019-2020 | |
| Philips North America LLC | $173.58 | 2022-2024 | (5044) Mcot |
| Braemar Manufacturing, LLC | $134.30 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $95.65 | 2021 | |
| Zoll Circulation INC | $67.62 | 2020 | |
| Convatec INC. | $61.78 | 2025 | |
| Novartis Pharmaceuticals Corporation | $53.76 | 2022-2023 | |
| Pfizer INC. | $51.31 | 2021-2023 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $38.22 | 2020-2021 | |
| Davol INC. | $30.66 | 2022 | |
| Cvrx, INC. | $23.48 | 2022-2025 | Barostim Neo System |
| Astrazeneca Pharmaceuticals LP | $21.91 | 2021 | |
| Irhythm Technologies, INC. | $18.29 | 2024 | Zio Monitor, Zio Xt Patch |
| Kiniksa Pharmaceuticals, LTD. | $15.47 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jigar Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.